CLINICAL TRIALS AT ENANTA

Enanta is committed to developing new treatments for viral infections and liver diseases. Enanta has active research and development programs in areas such as respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH), hepatitis B virus (HBV), human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19).

If you are a healthcare professional interested in learning more about Enanta’s clinical trials, please contact: Nathalie Adda, MD at nadda@enanta.com.

Learn more about any of our clinical trials described below by clicking the ClinicalTrials.gov. identifier listed below the description of the trial.

Non-Alcoholic Steatohepatitis

A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects With Liver Biopsy Proven Non-Alcoholic Steatohepatitis (NASH) (ARGON-2)
Clinicaltrials.gov identifier: NCT04378010

A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Study of Orally Administered EDP-297 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (SAD), Multiple Ascending Doses (MAD), and the Effect of Food on EDP-297 Pharmacokinetics in Healthy Subjects
ClinicalTrials.gov Identifier: NCT04559126

Respiratory Syncytial Virus

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of EDP-938 Administered Orally for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Ambulatory Adult Subjects (RSVP)

Clinicaltrials.gov identifier: NCT04196101
To visit the clinical trial website for RSVP!, click here

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of EDP-938 in Hematopoietic Cell Transplant Recipients with Acute RSV Infection and Symptoms of Upper Respiratory Tract Infection (RSVTx)
ClinicalTrials.gov Identifier: NCT04633187


A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Two-Part Study to Evaluate EDP-938 in Regimens in Subjects Aged 28 Days to 24 Months Infected with Respiratory Syncytial Virus (RSV) (RSVPEDs to initiate in Q1 2021)

ClinicalTrials.gov Identifier: NCT04816721
To visit the clinical trial website for RSVPEDs, click here

Hepatitis B Virus

A study of EDP-514 in Healthy Subjects (Part 1) and Patients with Chronic Hepatitis B Virus Infection (Part 2)
Clinicaltrials.gov identifier: NCT04008004

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
ClinicalTrials.gov Identifier: NCT04470388